Medicare Enrolled
Dr. Shreya Parikh, M.D.
Endocrinology · Sugar Land, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Parikh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parikh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parikh
Dr. Shreya Parikh is an endocrinology specialist in Sugar Land, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Parikh performed 2,879 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Parikh received a total of $138,168 from 65 pharmaceutical and/or device companies across 2279 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parikh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 15% volume in TX
$138,168 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,879
Medicare services
Top 15% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,124 | $86 | $207 |
| Denosumab injection (Prolia/Xgeva) | 782 | $18 | $31 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
393 | $26 | $86 |
| Diabetes self-management training, individual Individualized education and training for managing diabetes, billed per 30-minute session. |
371 | $41 | $103 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
47 | $45 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $110 | $319 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
34 | $81 | $220 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
27 | $110 | $294 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
25 | $11 | $48 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $138 | $280 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $61 | $141 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$138,168
Total received (2018-2024)
Avg $19,738/year across 7 years
Top 10% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
2,279
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$17,159
2023
$16,868
2022
$12,376
2021
$8,706
2020
$18,063
2019
$47,437
2018
$17,560
Payments by company (2024)
Abbott Laboratories
$12,302
Senseonics, Incorporated
$800
Dexcom, Inc.
$740
Lilly USA, LLC
$432
Embecta Corp.
$353
Novo Nordisk Inc
$345
AstraZeneca Pharmaceuticals LP
$339
Radius Health, Inc.
$269
Bayer Healthcare Pharmaceuticals Inc.
$218
Insulet Corporation
$181
Corcept Therapeutics
$165
Amgen Inc.
$150
BETA BIONICS, INC.
$96
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
Tandem Diabetes Care, Inc.
$86
Mannkind Corporation
$86
IBSA Pharma Inc.
$82
CeQur Corporation
$77
SANOFI-AVENTIS U.S. LLC
$63
Amphastar Pharmaceuticals, Inc.
$52
Amneal Pharmaceuticals LLC
$36
Antares Pharma, Inc.
$35
ABBVIE INC.
$33
Verity Pharmaceuticals Inc.
$28
Acella Pharmaceuticals, LLC
$20
Xeris Pharmaceuticals, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$19
Tolmar, Inc.
$18
Kyowa Kirin, Inc.
$16
TheracosBio, LLC
$5
Top 3 companies account for 80.7% of 2024 payments
All-time payments by company (2018-2024) ›
Valeritas, Inc.
$39,720
Abbott Laboratories
$34,820
Tandem Diabetes Care, Inc.
$24,273
MannKind Corporation
$5,692
AstraZeneca Pharmaceuticals LP
$4,308
Novo Nordisk Inc
$3,747
Ascensia Diabetes Care Us Inc.
$3,715
Zealand Pharma US, Inc.
$2,510
Lilly USA, LLC
$2,506
Dexcom, Inc.
$2,368
Amgen Inc.
$1,384
Senseonics, Incorporated
$1,217
Radius Health, Inc.
$1,214
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,172
Amarin Pharma Inc.
$1,096
SANOFI-AVENTIS U.S. LLC
$1,066
Insulet Corporation
$725
Bayer Healthcare Pharmaceuticals Inc.
$549
DEXCOM, INC.
$450
Mannkind Corporation
$450
Embecta Corp.
$353
Intuity Medical Inc
$328
Janssen Pharmaceuticals, Inc
$322
Merck Sharp & Dohme Corporation
$312
Xeris Pharmaceuticals, Inc.
$297
Corcept Therapeutics
$268
Horizon Therapeutics plc
$253
AbbVie Inc.
$248
Bigfoot Biomedical Inc
$231
CeQur Corporation
$230
IBSA Pharma Inc.
$222
AbbVie, Inc.
$207
ABBVIE INC.
$195
Amneal Pharmaceuticals LLC
$184
Antares Pharma, Inc.
$162
Becton, Dickinson and Company
$128
BETA BIONICS, INC.
$96
Medtronic, Inc.
$95
Shire North American Group Inc
$90
Currax Pharmaceuticals LLC
$85
Orexigen Therapeutics, Inc.
$75
Amphastar Pharmaceuticals, Inc.
$71
Esperion Therapeutics, Inc.
$70
Novartis Pharmaceuticals Corporation
$69
Alexion Pharmaceuticals, Inc.
$64
Companion Medical, Inc.
$53
LifeScan, Inc.
$49
Merck Sharp & Dohme LLC
$45
EISAI INC.
$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$34
Tolmar, Inc.
$33
Endo Pharmaceuticals Inc.
$30
Bayer HealthCare Pharmaceuticals Inc.
$28
Verity Pharmaceuticals Inc.
$28
Astellas Pharma US Inc
$26
Eisai Inc.
$26
Acella Pharmaceuticals, LLC
$20
PFIZER INC.
$19
RECORDATI_RARE_DISEASES_INC.
$19
Roche Diabetes Care, Inc.
$18
Kyowa Kirin, Inc.
$16
VIVUS LLC
$15
Nalpropion Pharmaceuticals LLC
$13
Althera Pharmaceuticals LLC
$12
TheracosBio, LLC
$5
Top 3 companies account for 71.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Androgel · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · Belviq · Brenzavvy · CONTRAVE · CYCLOSET · Cables · CeQur Simplicity · Crysvita · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ELIGARD · ENTRESTO · EVENITY · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKAMET · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Kits and Accessories · Korlym · LEQVIO · LINZESS · LOKELMA · LYUMJEV · MOUNJARO · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · Omnipod · OneTouch · Ozempic · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · RECORLEV · RYBELSUS · Repatha · Roszet · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SPIRIVA RESPIMAT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Software · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · Victoza · Wegovy · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
119
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Parikh is a clinical cardiology specialist, with above-average Medicare volume (top 15% in TX), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Parikh experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Parikh performed 1,124 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Parikh receive payments from pharmaceutical companies?
Yes. Dr. Parikh received a total of $138,168 from 65 companies across 2,279 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parikh's costs compare to other endocrinologists in Sugar Land?
Dr. Parikh's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parikh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Sugar Land
Browse endocrinologists in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in TX
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in TX
Which TX endocrinologists receive the most from drug and device companies.
By company
Valeritas, Inc. Payments to Doctors
See all physicians who received payments from Valeritas, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Tandem Diabetes Care, Inc. Payments to Doctors
See all physicians who received payments from Tandem Diabetes Care, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology